On the recordJanuary 7, 2020
Extending immunosuppressive drug coverage for the lifetime of kidney patients is a cost-effective way for the Federal Government to improve clinical outcomes for those with end-stage renal disease.
Source
congress.govGreg Walden: “Extending immunosuppressive drug coverage for the lifetime of kidney patients is a cost-effective way for the Federal…”
Editor's note · Context
Walden advocates for lifetime coverage of immunosuppressive drugs for kidney patients to improve outcomes.
Share
More from Greg Walden
Mar 10, 2023
The FCC Process Reform Act is bipartisan legislation that passed the House on March 11 of this year and would bring needed reforms to the commission's processes.
Dec 9, 2020
It is a great privilege now to recognize the gentleman from Kentucky (Mr. Guthrie), who is the top Republican on the Oversight and Investigations Subcommittee and has really done incredible work as we put together our package on Operation…
Dec 9, 2020
I have no other speakers on my side of the aisle. It is good legislation, bipartisan. It should become law. I urge its passage, and I yield back the balance of my time.
Other voices in this conversation
